Free Trial

Microchip Technology (MCHP) Financials

Microchip Technology logo
$59.57 -2.11 (-3.43%)
As of 02:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Microchip Technology

Annual Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
324 165 255 356 571 349 1,286 2,238 1,907 -2.70 119
Consolidated Net Income / (Loss)
324 165 255 356 571 349 1,286 2,238 1,907 -0.50 230
Net Income / (Loss) Continuing Operations
324 171 255 356 571 349 1,286 2,238 1,907 -0.50 230
Total Pre-Tax Income
281 90 737 205 150 340 1,483 2,910 2,366 39 274
Total Operating Income
352 276 936 714 647 998 1,850 3,116 2,571 296 490
Total Gross Profit
1,206 1,757 2,421 2,931 3,242 3,379 4,450 5,698 4,996 2,468 2,721
Total Revenue
2,173 3,408 3,981 5,350 5,274 5,438 6,821 8,439 7,634 4,402 4,713
Operating Revenue
2,173 3,408 3,981 5,350 5,274 5,438 6,821 8,439 7,634 4,402 4,713
Total Cost of Revenue
968 1,651 1,560 2,418 2,032 2,060 2,371 2,741 2,639 1,934 1,992
Operating Cost of Revenue
968 1,651 1,560 2,418 2,032 2,060 2,371 2,741 2,639 1,934 1,992
Total Operating Expenses
853 1,481 1,484 2,217 2,595 2,381 2,600 2,582 2,425 2,172 2,231
Selling, General & Admin Expense
302 500 452 683 677 610 719 798 734 618 674
Research & Development Expense
373 545 529 826 878 836 989 1,118 1,097 984 1,086
Amortization Expense
175 338 486 674 994 932 863 670 605 491 431
Other Special Charges / (Income)
4.00 99 18 34 47 1.70 30 -4.00 -12 79 40
Total Other Income / (Expense), net
-71 -186 -199 -510 -497 -659 -367 -206 -205 -257 -217
Interest Expense
104 190 215 516 503 657 370 212 211 261 221
Interest & Investment Income
24 2.90 22 7.90 2.80 1.70 0.50 2.10 7.60 9.20 11
Other Income / (Expense), net
8.90 1.30 -5.80 -2.20 3.20 -3.80 2.80 3.80 -2.20 -5.70 -6.70
Income Tax Expense
-43 -81 482 -151 -420 -9.90 197 672 459 39 44
Preferred Stock Dividends Declared
- - - - - - - 0.00 0.00 2.20 111
Basic Earnings per Share
$1.59 $0.76 $1.10 $1.51 $1.19 $0.67 $2.33 $4.07 $3.52 ($0.01) $0.22
Weighted Average Basic Shares Outstanding
203.40M 217.20M 232.90M 236.20M 477.70M 519.20M 552.30M 550.40M 542M 537.30M 540.40M
Diluted Earnings per Share
$1.49 $0.71 $1.03 $1.42 $1.11 $0.65 $2.27 $4.02 $3.48 ($0.01) $0.22
Weighted Average Diluted Shares Outstanding
217.40M 234.80M 248.90M 249.90M 512.40M 541.20M 565.90M 557.30M 548M 537.30M 545.20M
Weighted Average Basic & Diluted Shares Outstanding
203.90M 216.60M 232.20M 235.70M 245.33M 273.53M 554.50M 545.38M 536.89M 539.40M 542.08M
Cash Dividends to Common per Share
$1.43 $1.44 $1.45 $1.46 $0.73 $0.75 $0.91 $1.26 $1.68 $1.82 $1.82

Quarterly Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
155 129 78 -54 -157 -46 14 35 116 202 374
Consolidated Net Income / (Loss)
155 129 78 -54 -155 -19 42 63 144 230 401
Net Income / (Loss) Continuing Operations
155 129 78 -54 -155 -19 42 63 144 230 401
Total Pre-Tax Income
200 162 92 -46 -168 -16 32 94 164 290 418
Total Operating Income
254 219 147 31 -100 32 89 152 217 337 465
Total Gross Profit
790 737 669 561 501 577 638 707 800 939 1,068
Total Revenue
1,326 1,241 1,164 1,026 971 1,076 1,140 1,186 1,311 1,485 1,622
Operating Revenue
1,326 1,241 1,164 1,026 971 1,076 1,140 1,186 1,311 1,485 1,622
Total Cost of Revenue
536 504 495 465 469 499 503 479 512 546 554
Operating Cost of Revenue
536 504 495 465 469 499 503 479 512 546 554
Total Operating Expenses
536 518 522 531 601 545 549 555 582 602 604
Selling, General & Admin Expense
162 151 157 158 152 159 172 169 174 184 187
Research & Development Expense
240 242 241 246 255 256 262 274 294 309 319
Amortization Expense
151 123 123 123 123 108 108 108 108 90 90
Other Special Charges / (Income)
-17 2.60 1.50 3.50 72 22 6.30 4.80 6.40 19 7.90
Total Other Income / (Expense), net
-54 -57 -55 -77 -68 -48 -57 -58 -54 -47 -47
Interest Expense
55 62 59 69 71 57 56 56 52 49 47
Interest & Investment Income
2.50 2.80 2.00 1.70 2.70 4.90 3.60 1.30 1.60 1.40 1.70
Other Income / (Expense), net
-1.20 1.70 2.00 -9.70 0.30 4.60 -4.40 -3.50 -3.40 0.50 -1.40
Income Tax Expense
45 33 13 7.50 -14 2.80 -9.90 31 20 60 16
Preferred Stock Dividends Declared
- 0.00 0.00 0.00 - 28 28 28 28 28 28
Basic Earnings per Share
$0.29 $0.24 $0.15 ($0.10) ($0.30) ($0.09) $0.03 $0.06 $0.22 $0.37 $0.69
Weighted Average Basic Shares Outstanding
542M 536.70M 536.70M 537.40M 537.30M 539.20M 540M 540.80M 540.40M 542.50M 543.60M
Diluted Earnings per Share
$0.29 $0.24 $0.14 ($0.10) ($0.29) ($0.09) $0.03 $0.06 $0.22 $0.37 $0.68
Weighted Average Diluted Shares Outstanding
548M 542.80M 542M 537.40M 537.30M 539.20M 545M 545.50M 545.20M 550.50M 550.60M
Weighted Average Basic & Diluted Shares Outstanding
536.89M 536.51M 537.01M 537.82M 539.40M 539.68M 540.45M 541.14M 542.08M 543.01M 544.22M
Cash Dividends to Common per Share
$0.45 $0.45 $0.45 $0.46 $0.46 $0.46 $0.46 $0.46 $0.45 $0.46 $0.46

Annual Cash Flow Statements for Microchip Technology

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
196 -1,183 -7.40 -473 -28 -121 37 -83 86 452 -531
Net Cash From Operating Activities
468 1,060 1,420 1,675 1,544 1,917 2,843 3,621 2,893 898 962
Net Cash From Continuing Operating Activities
468 1,060 1,420 1,669 1,544 1,917 2,843 3,621 2,893 898 962
Net Income / (Loss) Continuing Operations
0.00 165 255 356 571 349 1,286 2,238 1,907 -0.50 230
Consolidated Net Income / (Loss)
- 165 255 356 571 349 1,286 2,238 1,907 -0.50 230
Depreciation Expense
283 469 616 876 1,216 1,153 1,144 998 880 750 689
Amortization Expense
52 61 113 131 139 88 56 17 45 73 33
Non-Cash Adjustments To Reconcile Net Income
71 197 120 183 176 492 327 181 192 182 260
Changes in Operating Assets and Liabilities, net
61 168 316 123 -557 -166 31 188 -130 -106 -250
Net Cash From Investing Activities
800 -2,838 -1,012 -6,811 -133 -173 -478 -600 -392 -288 -196
Net Cash From Continuing Investing Activities
14 -2,838 -1,012 -6,811 -133 -173 -478 -600 -392 -288 -196
Purchase of Property, Plant & Equipment
- -86 -214 -248 -139 -182 -492 -600 -399 -291 -202
Other Investing Activities, net
- - - - - - 0.00 0.90 6.40 2.80 6.40
Net Cash From Financing Activities
-60 596 -415 4,664 -1,438 -1,864 -2,328 -3,105 -2,415 -158 -1,298
Net Cash From Continuing Financing Activities
-286 596 -415 4,664 -1,438 -1,864 -2,328 -3,105 -2,415 -158 -1,298
Repayment of Debt
-2.20 -3,255 -75 -4,368 -2,716 -8,979 -6,557 -7,405 -17,596 -17,629 -7,463
Repurchase of Common Equity
- - - - 0.00 0.00 -426 -946 -982 -97 0.00
Payment of Dividends
-291 -315 -338 -344 -350 -388 -504 -695 -912 -976 -1,093
Issuance of Debt
0.00 4,182 0.00 9,406 1,638 7,544 5,173 5,935 17,055 17,248 7,316
Issuance of Preferred Equity
- - - - - - - 0.00 0.00 1,450 0.00
Issuance of Common Equity
29 42 42 43 59 60 71 82 82 65 62
Other Financing Activities, net
-22 -58 -44 -73 -69 -101 -85 -77 -63 -219 -121
Cash Interest Paid
- - 85 348 355 - - 182 191 236 211
Cash Income Taxes Paid
- - 26 78 101 - - 483 517 175 0.00

Quarterly Cash Flow Statements for Microchip Technology

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
39 -4.60 -29 300 186 -205 -330 14 -10 32 185
Net Cash From Operating Activities
430 377 44 272 206 276 88 341 257 512 419
Net Cash From Continuing Operating Activities
430 377 44 272 206 276 88 341 257 512 419
Net Income / (Loss) Continuing Operations
155 129 78 -54 -155 -19 42 63 144 230 401
Consolidated Net Income / (Loss)
155 129 78 -54 -155 -19 42 63 144 230 401
Depreciation Expense
218 189 188 187 187 171 173 172 174 157 156
Amortization Expense
20 19 14 25 15 2.80 6.60 14 9.50 6.20 4.70
Non-Cash Adjustments To Reconcile Net Income
43 44 46 -76 168 55 62 73 70 75 72
Changes in Operating Assets and Liabilities, net
-6.50 -3.50 -283 189 -9.30 65 -195 20 -140 44 -215
Net Cash From Investing Activities
-71 -126 -64 -42 -56 -37 -62 -45 -52 -52 -100
Net Cash From Continuing Investing Activities
-71 -126 -64 -42 -56 -37 -62 -45 -52 -52 -100
Purchase of Property, Plant & Equipment
-76 -126 -67 -42 -56 -42 -64 -45 -52 -52 -100
Other Investing Activities, net
4.90 0.10 2.40 -0.10 0.40 4.80 1.60 - - 0.10 0.10
Net Cash From Financing Activities
-320 -256 -8.40 71 36 -444 -356 -283 -215 -428 -135
Net Cash From Continuing Financing Activities
-320 -256 -8.40 71 36 -444 -356 -283 -215 -428 -135
Repayment of Debt
-6,896 -4,653 -2,534 -5,883 -4,559 -177 -1,677 -2,810 -2,799 -1,604 -1,208
Payment of Dividends
-243 -243 -244 -245 -245 -271 -274 -274 -274 -275 -275
Issuance of Debt
7,196 4,823 2,781 6,205 3,438 0.00 1,588 2,799 2,929 1,467 1,356
Issuance of Common Equity
24 13 21 12 20 12 18 12 19 13 21
Other Financing Activities, net
-15 -124 -15 -12 -68 -8.80 -12 -10 -90 -28 -29

Annual Balance Sheets for Microchip Technology

This table presents Microchip Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
5,538 7,687 8,257 18,350 17,426 16,479 16,200 16,370 15,873 15,375 14,370
Total Current Assets
3,097 2,305 3,356 2,215 2,217 2,145 2,453 3,069 3,013 2,991 2,378
Cash & Equivalents
2,093 909 901 429 401 280 317 234 320 772 240
Accounts Receivable
290 478 564 881 934 998 1,073 1,305 1,144 690 895
Inventories, net
307 417 476 712 686 665 854 1,325 1,316 1,294 1,035
Other Current Assets
12 59 120 192 195 201 206 205 234 236 207
Plant, Property, & Equipment, net
609 683 768 997 876 855 968 1,178 1,195 1,184 1,107
Total Noncurrent Assets
1,832 4,699 4,133 15,139 14,333 13,479 12,779 12,123 11,666 11,200 10,886
Goodwill
1,013 2,299 2,299 6,664 6,665 6,671 6,674 6,674 6,675 6,685 6,696
Intangible Assets
606 2,148 1,662 6,686 5,702 4,795 4,043 3,369 2,782 2,389 2,033
Noncurrent Deferred & Refundable Income Taxes
15 69 100 1,677 1,749 1,749 1,797 1,623 1,597 1,728 1,793
Other Noncurrent Operating Assets
79 75 72 112 217 264 265 457 612 398 364
Total Liabilities & Shareholders' Equity
5,538 7,687 8,257 18,350 17,426 16,479 16,200 16,370 15,873 15,375 14,370
Total Liabilities
3,387 4,416 4,977 13,063 11,841 11,142 10,305 9,857 9,215 8,296 7,938
Total Current Liabilities
382 705 2,017 2,375 1,637 2,410 1,399 3,119 2,519 1,155 1,136
Accounts Payable
79 149 144 226 247 292 345 397 213 161 206
Accrued Expenses
119 213 230 787 782 794 1,054 1,324 1,307 995 931
Total Noncurrent Liabilities
3,005 3,712 2,960 10,688 10,203 8,732 8,906 6,738 6,696 7,141 6,801
Long-Term Debt
2,453 2,901 1,758 8,946 8,873 7,581 7,687 5,042 5,000 5,630 5,496
Noncurrent Deferred Revenue
111 185 755 756 668 690 705 706 649 633 571
Noncurrent Deferred & Payable Income Tax Liabilities
399 409 206 706 319 44 40 43 29 34 25
Other Noncurrent Operating Liabilities
41 217 241 280 343 417 474 948 1,018 844 709
Total Equity & Noncontrolling Interests
2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658 7,078 6,432
Total Preferred & Common Equity
2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658 7,078 6,432
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658 7,078 6,432
Common Stock
1,392 2,538 2,563 2,680 2,675 2,404 2,537 2,414 2,483 3,911 4,072
Retained Earnings
1,583 1,479 1,397 3,211 3,432 3,394 4,175 5,764 6,760 5,781 4,916
Treasury Stock
-820 -732 -663 -582 -501 -434 -796 -1,660 -2,582 -2,612 -2,551
Accumulated Other Comprehensive Income / (Loss)
-3.36 -14 -18 -21 -22 -26 -21 -4.10 -3.50 -1.70 -4.20

Quarterly Balance Sheets for Microchip Technology

This table presents Microchip Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025 6/30/2026 9/30/2026
Total Assets
16,601 16,143 15,873 15,840 15,622 15,632 14,980 14,470 14,326 14,407 14,660
Total Current Assets
3,526 3,220 3,013 2,948 2,906 2,996 2,754 2,350 2,291 2,486 2,746
Cash & Equivalents
257 281 320 315 286 586 567 237 251 272 457
Accounts Receivable
1,706 1,398 1,144 1,096 1,044 857 766 746 731 968 963
Inventories, net
1,331 1,311 1,316 1,308 1,340 1,356 1,169 1,095 1,058 1,047 1,117
Other Current Assets
233 229 234 229 236 196 253 272 251 199 209
Plant, Property, & Equipment, net
1,207 1,208 1,195 1,196 1,171 1,152 1,154 1,154 1,130 1,084 1,074
Total Noncurrent Assets
11,868 11,715 11,666 11,695 11,546 11,484 11,072 10,966 10,905 10,837 10,840
Goodwill
6,675 6,675 6,675 6,682 6,682 6,685 6,695 6,696 6,696 6,696 6,703
Intangible Assets
3,089 2,937 2,782 2,776 2,655 2,518 2,292 2,170 2,099 2,001 1,921
Noncurrent Deferred & Refundable Income Taxes
1,576 1,538 1,597 1,601 1,638 1,704 1,735 1,739 1,743 1,782 1,821
Other Noncurrent Operating Assets
528 565 612 637 572 577 350 362 368 358 395
Total Liabilities & Shareholders' Equity
16,601 16,143 15,873 15,840 15,622 15,632 14,980 14,470 14,326 14,407 14,660
Total Liabilities
9,633 9,063 9,215 9,434 9,346 9,601 8,122 7,774 7,765 7,956 8,020
Total Current Liabilities
3,413 3,293 2,519 1,520 3,286 1,330 1,190 1,044 1,059 1,294 1,225
Accounts Payable
284 242 213 196 204 196 162 170 161 229 262
Accrued Expenses
1,468 1,389 1,307 1,324 1,135 1,134 1,029 874 899 1,066 962
Total Noncurrent Liabilities
6,220 5,770 6,696 7,913 6,061 8,270 6,932 6,730 6,706 6,662 6,795
Long-Term Debt
4,415 4,033 5,000 6,168 4,477 6,750 5,458 5,376 5,366 5,361 5,517
Noncurrent Deferred Revenue
679 635 649 656 590 599 640 561 573 580 593
Noncurrent Deferred & Payable Income Tax Liabilities
34 33 29 32 30 23 36 35 30 25 24
Other Noncurrent Operating Liabilities
1,093 1,068 1,018 1,058 964 899 797 758 738 695 661
Total Equity & Noncontrolling Interests
6,969 7,080 6,658 6,406 6,276 6,032 6,857 6,696 6,560 6,451 6,641
Total Preferred & Common Equity
6,969 7,080 6,658 6,406 6,276 6,032 6,857 6,696 6,560 6,451 6,641
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
6,969 7,080 6,658 6,406 6,276 6,032 6,857 6,696 6,560 6,451 6,641
Common Stock
2,415 2,446 2,483 2,405 2,446 2,482 3,975 4,029 4,092 4,116 4,155
Retained Earnings
6,666 6,847 6,760 6,646 6,481 6,183 5,489 5,257 5,046 4,871 4,997
Treasury Stock
-2,109 -2,209 -2,582 -2,641 -2,643 -2,630 -2,600 -2,585 -2,571 -2,533 -2,509
Accumulated Other Comprehensive Income / (Loss)
-2.80 -4.80 -3.50 -3.70 -7.80 -3.30 -6.40 -6.20 -6.70 -3.70 -2.90

Annual Metrics And Ratios for Microchip Technology

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 541,135,458.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 541,135,458.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.22% 56.80% 16.81% 34.38% -1.41% 3.11% 25.42% 23.72% -9.53% -42.35% 7.08%
EBITDA Growth
-5.24% 15.87% 105.65% 3.62% 16.59% 11.53% 36.52% 35.47% -15.52% -68.13% 8.31%
EBIT Growth
-17.79% -23.28% 235.80% -23.47% -8.68% 52.90% 86.30% 68.42% -17.66% -88.69% 66.35%
NOPAT Growth
-9.76% 29.16% -38.10% 283.29% 97.49% -58.16% 56.13% 49.42% -13.53% -100.18% 10,921.89%
Net Income Growth
-11.34% -49.18% 55.16% 39.35% 60.33% -38.77% 267.92% 74.07% -14.78% -100.03% 46,100.00%
EPS Growth
-9.70% -52.35% 45.07% 37.86% 60.33% -38.77% 249.23% 77.09% -13.43% -100.29% 2,300.00%
Operating Cash Flow Growth
23.89% 126.53% 33.99% 17.98% -7.82% 24.14% 48.33% 27.38% -20.11% -68.95% 7.13%
Free Cash Flow Firm Growth
-1,184.88% -1,305.39% 143.62% -1,099.55% 130.24% -41.34% 32.75% 27.80% -16.53% -83.82% 66.37%
Invested Capital Growth
38.32% 135.54% -13.59% 265.26% -3.29% -4.81% -4.99% -4.10% -3.00% -3.25% -2.08%
Revenue Q/Q Growth
0.67% 11.27% 2.57% 6.52% -0.06% 2.66% 5.85% 4.83% -10.62% -7.47% 7.79%
EBITDA Q/Q Growth
-5.62% 21.85% 7.20% 9.63% -2.78% 4.79% 8.61% 6.20% -14.76% -25.89% 32.43%
EBIT Q/Q Growth
-11.94% 38.75% 8.75% 9.88% -16.75% 16.80% 15.01% 10.62% -18.83% -54.80% 185.36%
NOPAT Q/Q Growth
-14.74% 94.50% -3.11% 35.88% 26.20% -12.74% 18.79% 6.22% -17.54% -100.77% 241.52%
Net Income Q/Q Growth
-8.80% 73.15% 4.00% 8.54% -11.59% 4.83% 33.41% 8.02% -19.07% -100.16% 434.30%
EPS Q/Q Growth
-8.02% 86.84% -0.96% 2.16% -11.59% 4.83% 30.46% 6.63% -20.18% -101.75% 175.86%
Operating Cash Flow Q/Q Growth
24.15% 59.88% 2.67% 2.69% -2.01% 4.21% 11.73% -1.04% -8.81% -19.97% 5.61%
Free Cash Flow Firm Q/Q Growth
38.90% 13.19% -9.55% 3.40% 22.18% -9.12% 11.71% -2.04% -6.69% -49.92% 3.23%
Invested Capital Q/Q Growth
-4.46% -3.63% -2.08% -0.68% -0.88% -0.75% -0.70% 0.86% -1.25% -2.12% 0.11%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
55.47% 51.56% 60.81% 54.80% 61.47% 62.13% 65.23% 67.52% 65.44% 56.07% 57.73%
EBITDA Margin
32.04% 23.68% 41.69% 32.14% 38.01% 41.11% 44.75% 49.00% 45.75% 25.29% 25.58%
Operating Margin
16.21% 8.09% 23.52% 13.35% 12.27% 18.35% 27.12% 36.93% 33.68% 6.73% 10.40%
EBIT Margin
16.62% 8.13% 23.37% 13.31% 12.33% 18.28% 27.16% 36.97% 33.65% 6.60% 10.26%
Profit (Net Income) Margin
14.90% 4.83% 6.42% 6.65% 10.82% 6.42% 18.85% 26.52% 24.98% -0.01% 4.88%
Tax Burden Percent
115.14% 183.30% 34.64% 174.03% 379.39% 102.92% 86.71% 76.90% 80.60% -1.29% 84.10%
Interest Burden Percent
77.88% 32.41% 79.24% 28.72% 23.13% 34.14% 80.03% 93.27% 92.10% 13.39% 56.58%
Effective Tax Rate
-15.14% -89.98% 65.36% -74.03% -279.39% -2.92% 13.29% 23.10% 19.40% 101.29% 15.90%
Return on Invested Capital (ROIC)
23.09% 15.31% 7.24% 12.87% 16.46% 7.18% 11.78% 18.45% 16.54% -0.03% 3.49%
ROIC Less NNEP Spread (ROIC-NNEP)
47.09% -35.21% 1.51% -3.64% -3.42% -0.48% 7.80% 16.11% 13.76% 0.03% -0.11%
Return on Net Nonoperating Assets (RNNOA)
-7.65% -9.24% 0.56% -4.56% -5.97% -0.78% 11.11% 17.62% 12.42% 0.02% -0.08%
Return on Equity (ROE)
15.44% 6.07% 7.80% 8.31% 10.50% 6.40% 22.89% 36.07% 28.96% -0.01% 3.40%
Cash Return on Invested Capital (CROIC)
-9.07% -65.48% 21.83% -101.15% 19.81% 12.11% 16.90% 22.63% 19.59% 3.27% 5.59%
Operating Return on Assets (OROA)
7.00% 4.19% 11.67% 5.35% 3.64% 5.87% 11.34% 19.16% 15.93% 1.86% 3.25%
Return on Assets (ROA)
6.28% 2.49% 3.20% 2.68% 3.19% 2.06% 7.87% 13.74% 11.83% 0.00% 1.55%
Return on Common Equity (ROCE)
15.44% 6.07% 7.80% 8.31% 10.50% 6.40% 22.89% 36.07% 28.96% -0.01% 3.40%
Return on Equity Simple (ROE_SIMPLE)
15.06% 5.03% 7.79% 6.73% 10.22% 6.55% 21.81% 34.35% 28.64% -0.01% 0.00%
Net Operating Profit after Tax (NOPAT)
406 524 324 1,243 2,455 1,027 1,604 2,396 2,072 -3.81 412
NOPAT Margin
18.67% 15.38% 8.15% 23.24% 46.55% 18.89% 23.51% 28.40% 27.14% -0.09% 8.74%
Net Nonoperating Expense Percent (NNEP)
-24.00% 50.52% 5.73% 16.51% 19.88% 7.66% 3.98% 2.34% 2.78% -0.06% 3.60%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - -0.03% 3.46%
Cost of Revenue to Revenue
44.53% 48.44% 39.19% 45.20% 38.53% 37.87% 34.77% 32.48% 34.56% 43.93% 42.27%
SG&A Expenses to Revenue
13.88% 14.67% 11.36% 12.77% 12.83% 11.22% 10.54% 9.45% 9.62% 14.03% 14.31%
R&D to Revenue
17.14% 16.00% 13.30% 15.45% 16.64% 15.38% 14.50% 13.25% 14.37% 22.35% 23.04%
Operating Expenses to Revenue
39.26% 43.47% 37.29% 41.44% 49.20% 43.78% 38.12% 30.60% 31.76% 49.34% 47.34%
Earnings before Interest and Taxes (EBIT)
361 277 931 712 650 994 1,852 3,120 2,569 291 483
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
696 807 1,659 1,719 2,005 2,236 3,052 4,135 3,493 1,113 1,206
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.94 4.32 5.87 3.40 2.70 7.37 6.76 6.83 7.21 3.65 5.44
Price to Tangible Book Value (P/TBV)
15.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.89 4.14 4.84 3.36 2.86 7.24 5.84 5.27 6.29 5.87 7.42
Price to Earnings (P/E)
26.12 85.74 75.38 50.53 26.45 112.63 30.98 19.89 25.16 0.00 294.30
Dividend Yield
3.45% 2.21% 1.76% 1.92% 2.33% 1.02% 1.27% 1.55% 1.89% 3.78% 2.82%
Earnings Yield
3.83% 1.17% 1.33% 1.98% 3.78% 0.89% 3.23% 5.03% 3.97% 0.00% 0.34%
Enterprise Value to Invested Capital (EV/IC)
4.10 3.26 4.85 1.84 1.65 3.44 3.56 3.99 4.35 2.57 3.44
Enterprise Value to Revenue (EV/Rev)
3.84 4.59 5.06 5.21 4.58 8.82 6.92 6.01 7.03 6.97 8.53
Enterprise Value to EBITDA (EV/EBITDA)
11.99 19.40 12.13 16.20 12.06 21.46 15.46 12.26 15.36 27.57 33.35
Enterprise Value to EBIT (EV/EBIT)
23.13 56.49 21.63 39.13 37.17 48.25 25.47 16.25 20.89 105.62 83.20
Enterprise Value to NOPAT (EV/NOPAT)
20.59 29.88 62.04 22.41 9.85 46.71 29.42 21.16 25.90 0.00 97.58
Enterprise Value to Operating Cash Flow (EV/OCF)
17.86 14.77 14.18 16.64 15.66 25.03 16.60 14.00 18.55 34.18 41.80
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 20.59 0.00 8.18 27.69 20.52 17.25 21.87 77.30 60.88
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.14 0.90 0.94 1.95 1.70 1.67 1.30 0.99 0.90 0.80 0.85
Long-Term Debt to Equity
1.14 0.89 0.54 1.69 1.59 1.42 1.30 0.77 0.75 0.80 0.85
Financial Leverage
-0.16 0.26 0.37 1.25 1.74 1.62 1.42 1.09 0.90 0.77 0.75
Leverage Ratio
2.46 2.44 2.43 3.11 3.29 3.10 2.91 2.62 2.45 2.27 2.20
Compound Leverage Factor
1.92 0.79 1.93 0.89 0.76 1.06 2.33 2.45 2.25 0.30 1.25
Debt to Total Capital
53.28% 47.43% 48.33% 66.09% 62.93% 62.52% 56.60% 49.72% 47.40% 44.30% 46.08%
Short-Term Debt to Total Capital
0.00% 0.80% 20.63% 8.73% 4.04% 9.29% 0.00% 10.79% 7.90% 0.00% 0.00%
Long-Term Debt to Total Capital
53.28% 46.62% 27.70% 57.37% 58.89% 53.23% 56.60% 38.92% 39.51% 44.30% 46.08%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
46.72% 52.57% 51.67% 33.91% 37.07% 37.48% 43.40% 50.28% 52.60% 55.70% 53.92%
Debt to EBITDA
3.52 3.66 1.85 5.99 4.73 3.98 2.52 1.56 1.72 5.06 4.56
Net Debt to EBITDA
-0.16 1.91 0.53 5.74 4.53 3.86 2.41 1.50 1.63 4.36 4.36
Long-Term Debt to EBITDA
3.52 3.59 1.06 5.20 4.43 3.39 2.52 1.22 1.43 5.06 4.56
Debt to NOPAT
6.05 5.63 9.46 8.29 3.86 8.67 4.79 2.69 2.90 -1,478.38 13.34
Net Debt to NOPAT
-0.27 2.94 2.69 7.94 3.70 8.39 4.59 2.59 2.74 -1,275.76 12.75
Long-Term Debt to NOPAT
6.05 5.54 5.42 7.20 3.61 7.38 4.79 2.10 2.41 -1,478.38 13.34
Altman Z-Score
3.10 3.00 3.61 1.48 1.51 2.92 3.56 4.34 4.77 2.89 3.66
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.11 3.27 1.66 0.93 1.35 0.89 1.75 0.98 1.20 2.59 2.09
Quick Ratio
7.16 2.53 1.37 0.55 0.82 0.53 1.00 0.49 0.58 1.27 1.00
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-159 -2,241 977 -9,769 2,954 1,733 2,300 2,940 2,454 397 661
Operating Cash Flow to CapEx
0.00% 1,695.20% 697.25% 677.23% 1,135.98% 1,105.89% 595.08% 604.00% 726.63% 309.05% 476.52%
Free Cash Flow to Firm to Interest Expense
-1.53 -11.78 4.55 -18.95 5.88 2.64 6.21 13.85 11.66 1.52 2.99
Operating Cash Flow to Interest Expense
4.50 5.57 6.60 3.25 3.07 2.92 7.67 17.06 13.74 3.44 4.35
Operating Cash Flow Less CapEx to Interest Expense
4.63 5.24 5.66 2.77 2.80 2.66 6.39 14.24 11.85 2.33 3.44
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.42 0.52 0.50 0.40 0.29 0.32 0.42 0.52 0.47 0.28 0.32
Accounts Receivable Turnover
7.71 8.87 7.64 7.41 5.81 5.63 6.59 7.10 6.23 4.80 5.95
Inventory Turnover
3.30 4.56 3.49 4.07 2.91 3.05 3.12 2.52 2.00 1.48 1.71
Fixed Asset Turnover
3.65 5.27 5.49 6.06 5.63 6.28 7.48 7.87 6.44 3.70 4.12
Accounts Payable Turnover
11.65 14.45 10.64 13.05 8.59 7.64 7.44 7.39 8.65 10.35 10.88
Days Sales Outstanding (DSO)
47.37 41.16 47.78 49.27 62.79 64.82 55.39 51.43 58.54 76.02 61.35
Days Inventory Outstanding (DIO)
110.55 80.05 104.51 89.65 125.50 119.68 116.94 145.11 182.65 246.28 213.37
Days Payable Outstanding (DPO)
31.34 25.27 34.31 27.96 42.50 47.78 49.03 49.38 42.18 35.26 33.55
Cash Conversion Cycle (CCC)
126.59 95.95 117.97 110.96 145.79 136.73 123.30 147.16 199.01 287.04 241.17
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,040 4,805 4,152 15,164 14,665 13,959 13,263 12,720 12,338 11,937 11,689
Invested Capital Turnover
1.24 1.00 0.89 0.55 0.35 0.38 0.50 0.65 0.61 0.36 0.40
Increase / (Decrease) in Invested Capital
565 2,765 -653 11,012 -499 -706 -696 -543 -382 -401 -249
Enterprise Value (EV)
8,353 15,654 20,123 27,861 24,174 47,977 47,190 50,705 53,667 30,695 40,219
Market Capitalization
8,464 14,114 19,251 17,985 15,094 39,355 39,822 44,499 47,987 25,836 34,963
Book Value per Share
$10.57 $15.11 $14.00 $22.31 $23.32 $19.82 $10.60 $11.89 $12.32 $13.16 $11.89
Tangible Book Value per Share
$2.61 ($5.44) ($2.91) ($34.02) ($28.31) ($22.76) ($8.67) ($6.44) ($5.18) ($3.71) ($4.24)
Total Capital
4,604 6,221 6,348 15,595 15,068 14,241 13,582 12,954 12,658 12,709 11,929
Total Debt
2,453 2,951 3,068 10,307 9,482 8,904 7,687 6,440 6,000 5,630 5,496
Total Long-Term Debt
2,453 2,901 1,758 8,946 8,873 7,581 7,687 5,042 5,000 5,630 5,496
Net Debt
-111 1,540 872 9,876 9,079 8,622 7,368 6,206 5,680 4,859 5,256
Capital Expenditures (CapEx)
-14 63 204 247 136 173 478 600 398 291 202
Debt-free, Cash-free Net Working Capital (DFCFNWC)
269 348 452 770 786 777 734 1,115 1,173 1,065 1,001
Debt-free Net Working Capital (DFNWC)
2,715 1,651 2,649 1,201 1,189 1,059 1,054 1,349 1,493 1,836 1,241
Net Working Capital (NWC)
2,715 1,601 1,339 -160 580 -264 1,054 -49 494 1,836 1,241
Net Nonoperating Expense (NNE)
82 359 69 887 1,884 678 318 159 165 -3.31 182
Net Nonoperating Obligations (NNO)
-111 1,534 872 9,876 9,079 8,622 7,368 6,206 5,680 4,859 5,256
Total Depreciation and Amortization (D&A)
335 530 729 1,007 1,354 1,242 1,200 1,015 924 823 722
Debt-free, Cash-free Net Working Capital to Revenue
12.36% 10.20% 11.36% 14.40% 14.90% 14.28% 10.76% 13.21% 15.37% 24.18% 21.24%
Debt-free Net Working Capital to Revenue
124.91% 48.43% 66.54% 22.45% 22.54% 19.46% 15.45% 15.98% 19.56% 41.72% 26.34%
Net Working Capital to Revenue
124.91% 46.97% 33.63% -2.99% 10.99% -4.86% 15.45% -0.58% 6.47% 41.72% 26.34%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.80 $0.38 $0.55 $0.76 $1.20 $0.68 $2.33 $4.07 $3.52 ($0.01) $0.22
Adjusted Weighted Average Basic Shares Outstanding
406.77M 434.39M 465.80M 472.40M 477.80M 519.20M 552.30M 550.40M 542M 537.30M 540.40M
Adjusted Diluted Earnings per Share
$0.75 $0.36 $0.52 $0.71 $1.12 $0.65 $2.27 $4.02 $3.48 ($0.01) $0.22
Adjusted Weighted Average Diluted Shares Outstanding
434.78M 469.61M 497.80M 499.80M 512.40M 541.20M 565.90M 557.30M 548M 537.30M 545.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.76 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
429.63M 458.80M 470.07M 475.85M 490.66M 547.06M 554.50M 545.38M 536.89M 539.40M 542.08M
Normalized Net Operating Profit after Tax (NOPAT)
249 262 668 524 486 700 1,629 2,393 2,062 263 446
Normalized NOPAT Margin
11.48% 7.69% 16.77% 9.79% 9.21% 12.87% 23.89% 28.36% 27.01% 5.97% 9.45%
Pre Tax Income Margin
12.94% 2.64% 18.52% 3.82% 2.85% 6.24% 21.73% 34.48% 30.99% 0.88% 5.80%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.47 1.46 4.33 1.38 1.29 1.51 5.00 14.70 12.20 1.11 2.18
NOPAT to Interest Expense
3.90 2.75 1.51 2.41 4.88 1.56 4.33 11.29 9.84 -0.01 1.86
EBIT Less CapEx to Interest Expense
3.61 1.13 3.38 0.90 1.02 1.25 3.71 11.88 10.31 0.00 1.27
NOPAT Less CapEx to Interest Expense
4.04 2.43 0.56 1.93 4.61 1.30 3.04 8.47 7.95 -1.13 0.95
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
89.87% 191.62% 132.15% 96.77% 61.36% 111.13% 39.19% 31.07% 47.80% -195,140.00% 475.00%
Augmented Payout Ratio
89.87% 191.62% 132.15% 96.77% 61.36% 111.13% 72.30% 73.34% 99.30% -214,440.00% 475.00%

Quarterly Metrics And Ratios for Microchip Technology

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 541,135,458.00 542,079,281.00 543,008,691.00
DEI Adjusted Shares Outstanding
- - - - - - - - 541,135,458.00 542,079,281.00 543,008,691.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.22 0.37 0.69
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-40.62% -45.76% -48.37% -41.89% -26.80% -13.36% -2.01% 15.59% 35.11% 38.05% 42.19%
EBITDA Growth
-55.21% -62.11% -68.35% -69.57% -79.24% -50.81% -24.63% 43.25% 289.79% 137.51% 136.35%
EBIT Growth
-70.26% -75.55% -83.15% -96.01% -139.64% -83.38% -43.14% 599.06% 314.00% 819.07% 448.05%
NOPAT Growth
-69.26% -75.32% -82.25% -95.28% -135.75% -87.17% -7.19% 369.81% 372.42% 1,088.15% 283.09%
Net Income Growth
-74.39% -80.60% -88.24% -112.79% -199.94% -114.39% -46.81% 216.98% 193.27% 1,335.48% 862.59%
EPS Growth
-73.64% -80.17% -88.43% -112.99% -200.00% -137.50% -78.57% 160.00% 175.86% 511.11% 2,166.67%
Operating Cash Flow Growth
-39.39% -62.03% -92.92% -68.18% -52.12% -26.92% 102.06% 25.75% 24.82% 85.60% 375.82%
Free Cash Flow Firm Growth
-51.11% -60.40% -50.91% -44.14% -42.78% 4.98% 38.77% 93.29% 32.99% -10.68% -16.48%
Invested Capital Growth
-3.00% -2.64% -2.93% -2.40% -3.25% -4.16% -4.66% -4.26% -2.08% -1.78% -1.13%
Revenue Q/Q Growth
-24.91% -6.37% -6.24% -11.84% -5.41% 10.82% 6.03% 4.00% 10.56% 13.23% 9.21%
EBITDA Q/Q Growth
-35.98% -12.78% -18.24% -33.34% -56.32% 106.67% 25.26% 26.69% 18.85% 25.93% 24.65%
EBIT Q/Q Growth
-52.53% -12.49% -32.70% -85.73% -571.70% 136.70% 130.25% 75.38% 44.40% 57.62% 37.30%
NOPAT Q/Q Growth
-57.15% -10.84% -28.26% -82.78% -424.60% 132.00% 418.81% -12.83% 88.22% 39.58% 67.28%
Net Income Q/Q Growth
-63.10% -16.42% -39.37% -168.37% -188.43% 87.97% 324.19% 50.36% 129.98% 59.36% 74.67%
EPS Q/Q Growth
-62.34% -17.24% -41.67% -171.43% -190.00% 68.97% 133.33% 100.00% 266.67% 68.18% 83.78%
Operating Cash Flow Q/Q Growth
-49.61% -12.30% -88.44% 522.71% -24.16% 33.85% -68.03% 287.51% -24.72% 99.03% -18.05%
Free Cash Flow Firm Q/Q Growth
0.51% -12.23% -1.32% -35.83% 2.94% 61.05% 30.44% -10.62% -29.17% 8.17% 21.97%
Invested Capital Q/Q Growth
-1.25% -0.64% 1.26% -1.75% -2.12% -1.58% 0.73% -1.34% 0.11% -1.27% 1.40%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
59.58% 59.37% 57.44% 54.72% 51.63% 53.62% 55.94% 59.60% 60.98% 63.24% 65.86%
EBITDA Margin
37.02% 34.49% 30.07% 22.74% 10.50% 19.58% 23.13% 28.18% 30.29% 33.69% 38.45%
Operating Margin
19.12% 17.65% 12.60% 3.01% -10.33% 2.98% 7.80% 12.79% 16.58% 22.68% 28.65%
EBIT Margin
19.03% 17.79% 12.77% 2.07% -10.30% 3.41% 7.41% 12.50% 16.32% 22.72% 28.56%
Profit (Net Income) Margin
11.67% 10.42% 6.74% -5.22% -15.93% -1.73% 3.66% 5.29% 11.00% 15.48% 24.75%
Tax Burden Percent
77.47% 79.91% 85.68% 116.27% 91.86% 117.72% 131.13% 66.99% 87.98% 79.27% 96.14%
Interest Burden Percent
79.15% 73.28% 61.57% -217.45% 168.30% -43.05% 37.63% 63.16% 76.59% 85.95% 90.15%
Effective Tax Rate
22.53% 20.09% 14.32% 0.00% 0.00% 0.00% -31.13% 33.01% 12.02% 20.73% 3.86%
Return on Invested Capital (ROIC)
9.03% 7.48% 4.71% 0.81% -2.62% 0.74% 3.55% 3.14% 5.82% 7.91% 13.11%
ROIC Less NNEP Spread (ROIC-NNEP)
8.32% 6.69% 3.92% -0.49% -4.23% -0.03% 2.22% 2.45% 4.89% 7.17% 12.23%
Return on Net Nonoperating Assets (RNNOA)
7.51% 5.87% 3.54% -0.43% -3.24% -0.02% 1.93% 2.19% 3.66% 5.37% 9.35%
Return on Equity (ROE)
16.54% 13.35% 8.25% 0.38% -5.87% 0.72% 5.48% 5.33% 9.48% 13.28% 22.47%
Cash Return on Invested Capital (CROIC)
19.59% 15.06% 10.58% 6.42% 3.27% 4.89% 5.07% 5.36% 5.59% 7.43% 9.77%
Operating Return on Assets (OROA)
9.01% 7.25% 4.36% 0.62% -2.90% 0.94% 2.07% 3.65% 5.17% 7.92% 10.99%
Return on Assets (ROA)
5.53% 4.24% 2.30% -1.56% -4.49% -0.48% 1.02% 1.54% 3.49% 5.40% 9.52%
Return on Common Equity (ROCE)
16.54% 13.35% 8.25% 0.38% -5.87% 0.72% 5.48% 5.33% 9.48% 13.28% 22.47%
Return on Equity Simple (ROE_SIMPLE)
0.00% 21.38% 12.45% 5.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
196 175 126 22 -70 22 117 102 191 267 447
NOPAT Margin
14.81% 14.11% 10.79% 2.11% -7.23% 2.09% 10.22% 8.57% 14.59% 17.98% 27.54%
Net Nonoperating Expense Percent (NNEP)
0.70% 0.79% 0.79% 1.30% 1.60% 0.76% 1.33% 0.69% 0.93% 0.75% 0.89%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.17% -0.55% 0.18% 0.97% 0.85% 1.60% 2.26% 3.67%
Cost of Revenue to Revenue
40.42% 40.63% 42.56% 45.28% 48.37% 46.38% 44.06% 40.40% 39.02% 36.76% 34.14%
SG&A Expenses to Revenue
12.20% 12.12% 13.49% 15.42% 15.66% 14.81% 15.11% 14.21% 13.29% 12.41% 11.53%
R&D to Revenue
18.12% 19.47% 20.68% 24.00% 26.30% 23.76% 23.00% 23.13% 22.41% 20.81% 19.64%
Operating Expenses to Revenue
40.46% 41.71% 44.84% 51.71% 61.97% 50.64% 48.14% 46.81% 44.40% 40.55% 37.22%
Earnings before Interest and Taxes (EBIT)
252 221 149 21 -100 37 85 148 214 337 463
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
491 428 350 233 102 211 264 334 397 500 624
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.21 7.63 6.86 5.11 3.65 5.54 5.18 5.25 5.44 7.66 6.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
6.29 7.42 7.84 6.47 5.87 8.96 8.23 7.88 7.42 9.65 7.54
Price to Earnings (P/E)
25.16 35.67 55.11 99.73 0.00 0.00 0.00 0.00 294.30 134.63 58.10
Dividend Yield
1.89% 1.92% 2.24% 3.16% 3.78% 2.58% 2.83% 2.86% 2.82% 2.00% 2.34%
Earnings Yield
3.97% 2.80% 1.81% 1.00% 0.00% 0.00% 0.00% 0.00% 0.34% 0.74% 1.72%
Enterprise Value to Invested Capital (EV/IC)
4.35 4.46 3.96 3.03 2.57 3.65 3.36 3.39 3.44 4.73 4.04
Enterprise Value to Revenue (EV/Rev)
7.03 8.31 8.95 7.77 6.97 10.12 9.45 9.05 8.53 10.65 8.44
Enterprise Value to EBITDA (EV/EBITDA)
15.36 19.60 24.18 24.60 27.57 47.83 49.16 43.44 33.35 36.46 25.49
Enterprise Value to EBIT (EV/EBIT)
20.89 29.00 42.68 57.49 105.62 402.34 938.62 233.49 83.20 69.55 40.68
Enterprise Value to NOPAT (EV/NOPAT)
25.90 35.55 51.38 74.92 0.00 560.05 1,101.81 327.75 97.58 83.06 46.52
Enterprise Value to Operating Cash Flow (EV/OCF)
18.55 24.03 28.88 32.94 34.18 53.79 47.32 43.42 41.80 45.51 30.93
Enterprise Value to Free Cash Flow (EV/FCFF)
21.87 29.24 36.92 46.61 77.30 73.05 64.79 61.80 60.88 63.02 41.11
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.90 0.96 1.02 1.12 0.80 0.80 0.80 0.82 0.85 0.83 0.83
Long-Term Debt to Equity
0.75 0.96 0.71 1.12 0.80 0.80 0.80 0.82 0.85 0.83 0.83
Financial Leverage
0.90 0.88 0.90 0.88 0.77 0.81 0.87 0.90 0.75 0.75 0.76
Leverage Ratio
2.45 2.44 2.43 2.42 2.27 2.32 2.32 2.38 2.20 2.21 2.18
Compound Leverage Factor
1.94 1.79 1.50 -5.27 3.83 -1.00 0.87 1.50 1.69 1.90 1.97
Debt to Total Capital
47.40% 49.05% 50.58% 52.81% 44.30% 44.32% 44.53% 44.99% 46.08% 45.39% 45.38%
Short-Term Debt to Total Capital
7.90% 0.00% 15.33% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
39.51% 49.05% 35.25% 52.81% 44.30% 44.32% 44.53% 44.99% 46.08% 45.39% 45.38%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
52.60% 50.95% 49.42% 47.19% 55.70% 55.68% 55.47% 55.01% 53.92% 54.61% 54.62%
Debt to EBITDA
1.72 2.21 3.16 4.49 5.06 6.09 6.64 5.89 4.56 3.59 2.97
Net Debt to EBITDA
1.63 2.10 3.01 4.10 4.36 5.46 6.35 5.62 4.36 3.40 2.73
Long-Term Debt to EBITDA
1.43 2.21 2.20 4.49 5.06 6.09 6.64 5.89 4.56 3.59 2.97
Debt to NOPAT
2.90 4.01 6.71 13.68 -1,478.38 71.34 148.83 44.46 13.34 8.17 5.43
Net Debt to NOPAT
2.74 3.80 6.41 12.49 -1,275.76 63.93 142.28 42.39 12.75 7.75 4.98
Long-Term Debt to NOPAT
2.41 4.01 4.67 13.68 -1,478.38 71.34 148.83 44.46 13.34 8.17 5.43
Altman Z-Score
4.29 4.26 3.70 2.92 2.80 3.73 3.60 3.60 3.60 4.73 4.25
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.20 1.94 0.88 2.25 2.59 2.31 2.25 2.16 2.09 1.92 2.24
Quick Ratio
0.58 0.93 0.40 1.08 1.27 1.12 0.94 0.93 1.00 0.96 1.16
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
578 507 501 321 331 533 695 621 440 476 580
Operating Cash Flow to CapEx
565.05% 300.24% 65.47% 644.89% 365.72% 660.91% 138.52% 767.19% 493.28% 981.77% 420.88%
Free Cash Flow to Firm to Interest Expense
10.49 8.21 8.47 4.66 4.66 9.28 12.34 11.11 8.51 9.75 12.27
Operating Cash Flow to Interest Expense
7.80 6.10 0.74 3.93 2.90 4.80 1.56 6.11 4.97 10.48 8.86
Operating Cash Flow Less CapEx to Interest Expense
6.42 4.07 -0.39 3.32 2.11 4.07 0.44 5.31 3.96 9.41 6.76
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.47 0.41 0.34 0.30 0.28 0.27 0.28 0.29 0.32 0.35 0.38
Accounts Receivable Turnover
6.23 5.14 4.00 4.22 4.80 4.55 4.71 5.51 5.95 5.91 6.56
Inventory Turnover
2.00 1.82 1.63 1.50 1.48 1.56 1.59 1.62 1.71 1.84 1.89
Fixed Asset Turnover
6.44 5.53 4.62 4.03 3.70 3.60 3.62 3.83 4.12 4.58 5.03
Accounts Payable Turnover
8.65 10.10 8.95 9.13 10.35 10.76 10.34 10.94 10.88 10.44 9.67
Days Sales Outstanding (DSO)
58.54 70.95 91.32 86.53 76.02 80.19 77.57 66.30 61.35 61.75 55.67
Days Inventory Outstanding (DIO)
182.65 200.01 223.43 243.38 246.28 234.46 229.61 225.95 213.37 198.38 193.21
Days Payable Outstanding (DPO)
42.18 36.13 40.80 39.97 35.26 33.91 35.29 33.37 33.55 34.98 37.75
Cash Conversion Cycle (CCC)
199.01 234.83 273.95 289.93 287.04 280.74 271.90 258.88 241.17 225.15 211.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
12,338 12,259 12,413 12,195 11,937 11,749 11,835 11,676 11,689 11,540 11,701
Invested Capital Turnover
0.61 0.53 0.44 0.39 0.36 0.35 0.35 0.37 0.40 0.44 0.48
Increase / (Decrease) in Invested Capital
-382 -332 -375 -300 -401 -510 -578 -519 -249 -209 -134
Enterprise Value (EV)
53,667 54,709 49,213 36,961 30,695 42,849 39,797 39,553 40,219 54,527 47,290
Market Capitalization
47,987 48,856 43,076 30,798 25,836 37,958 34,658 34,437 34,963 49,438 42,230
Book Value per Share
$12.32 $11.93 $11.70 $11.23 $13.16 $12.71 $12.41 $12.14 $11.89 $11.90 $12.23
Tangible Book Value per Share
($5.18) ($5.68) ($5.70) ($5.91) ($3.71) ($3.95) ($4.02) ($4.13) ($4.24) ($4.14) ($3.65)
Total Capital
12,658 12,574 12,699 12,781 12,709 12,315 12,071 11,926 11,929 11,812 12,158
Total Debt
6,000 6,168 6,423 6,750 5,630 5,458 5,376 5,366 5,496 5,361 5,517
Total Long-Term Debt
5,000 6,168 4,477 6,750 5,630 5,458 5,376 5,366 5,496 5,361 5,517
Net Debt
5,680 5,853 6,137 6,164 4,859 4,892 5,139 5,115 5,256 5,089 5,060
Capital Expenditures (CapEx)
76 126 67 42 56 42 64 45 52 52 100
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,173 1,113 1,280 1,080 1,065 997 1,070 981 1,001 920 1,065
Debt-free Net Working Capital (DFNWC)
1,493 1,428 1,566 1,666 1,836 1,563 1,307 1,231 1,241 1,192 1,522
Net Working Capital (NWC)
494 1,428 -380 1,666 1,836 1,563 1,307 1,231 1,241 1,192 1,522
Net Nonoperating Expense (NNE)
42 46 47 75 84 41 75 39 47 37 45
Net Nonoperating Obligations (NNO)
5,680 5,853 6,137 6,164 4,859 4,892 5,139 5,115 5,256 5,089 5,060
Total Depreciation and Amortization (D&A)
239 207 201 212 202 174 179 186 183 163 160
Debt-free, Cash-free Net Working Capital to Revenue
15.37% 16.90% 23.29% 22.69% 24.18% 23.54% 25.39% 22.43% 21.24% 17.95% 19.00%
Debt-free Net Working Capital to Revenue
19.56% 21.68% 28.49% 35.01% 41.72% 36.91% 31.02% 28.16% 26.34% 23.27% 27.15%
Net Working Capital to Revenue
6.47% 21.68% -6.92% 35.01% 41.72% 36.91% 31.02% 28.16% 26.34% 23.27% 27.15%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.29 $0.24 $0.15 ($0.10) ($0.30) ($0.09) $0.03 $0.06 $0.22 $0.37 $0.69
Adjusted Weighted Average Basic Shares Outstanding
542M 536.70M 536.70M 537.40M 537.30M 539.20M 540M 540.80M 540.40M 542.50M 543.60M
Adjusted Diluted Earnings per Share
$0.29 $0.24 $0.14 ($0.10) ($0.29) ($0.09) $0.03 $0.06 $0.22 $0.37 $0.68
Adjusted Weighted Average Diluted Shares Outstanding
548M 542.80M 542M 537.40M 537.30M 539.20M 545M 545.50M 545.20M 550.50M 550.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
536.89M 536.51M 537.01M 537.82M 539.40M 539.68M 540.45M 541.14M 542.08M 543.01M 544.22M
Normalized Net Operating Profit after Tax (NOPAT)
183 177 127 24 -20 38 67 105 197 282 454
Normalized NOPAT Margin
13.82% 14.27% 10.90% 2.35% -2.07% 3.53% 5.84% 8.84% 15.02% 18.99% 28.01%
Pre Tax Income Margin
15.06% 13.03% 7.86% -4.49% -17.34% -1.47% 2.79% 7.89% 12.50% 19.53% 25.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.58 3.57 2.51 0.31 -1.41 0.64 1.50 2.65 4.14 6.91 9.79
NOPAT to Interest Expense
3.56 2.83 2.13 0.31 -0.99 0.39 2.07 1.82 3.70 5.47 9.44
EBIT Less CapEx to Interest Expense
3.20 1.54 1.39 -0.30 -2.20 -0.09 0.37 1.86 3.13 5.84 7.69
NOPAT Less CapEx to Interest Expense
2.18 0.80 1.00 -0.30 -1.78 -0.34 0.94 1.02 2.69 4.40 7.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
47.80% 69.00% 123.62% 315.22% -195,140.00% -676.35% -558.40% -1,544.91% 475.00% 229.22% 131.06%
Augmented Payout Ratio
99.30% 135.76% 199.36% 471.92% -214,440.00% -692.39% -561.91% -1,544.91% 475.00% 229.22% 131.06%

Financials Breakdown Chart

Key Financial Trends

Microchip Technology (NASDAQ:MCHP) is showing a meaningful operating recovery. Revenue increased to $1.48 billion in Q1 fiscal 2027 from $1.31 billion in Q4 fiscal 2026 and $1.08 billion in Q1 fiscal 2026. Gross profit rose to $938.9 million, lifting the gross margin to approximately 63.2%, while operating income increased to $336.8 million, or 22.7% of revenue. This compares with an operating margin of 16.6% in the prior quarter and just 3.0% in Q1 fiscal 2026.

Profitability and cash generation also improved. Net income reached $229.8 million, compared with $144.2 million in the prior quarter and a $18.6 million loss in Q1 fiscal 2026. Operating cash flow climbed to $511.5 million, the strongest quarterly result in the provided fiscal 2026-2027 data. After $52.0 million of capital expenditures, estimated free cash flow was approximately $459.5 million.

The balance sheet remains mixed. Microchip reduced long-term debt modestly to $5.36 billion from more than $6.16 billion in Q1 fiscal 2025 and $7.69 billion at the end of fiscal 2022. However, cash and equivalents fell to $272.3 million from $566.5 million one year earlier, and goodwill plus intangible assets totaled approximately $8.70 billion, or roughly 60% of total assets. Investors should also note that preferred dividends exceeded net income attributable to common shareholders in the latest quarter, while the company continued to pay a common dividend of $0.455 per share.

  • Revenue recovery: Quarterly revenue has risen for four consecutive reported periods, from $1.03 billion in Q3 fiscal 2026 to $1.48 billion in Q1 fiscal 2027.
  • Strong margin expansion: Gross margin improved to approximately 63.2% and operating margin to 22.7% in the latest quarter.
  • Improved earnings: Net income increased nearly 60% sequentially and returned to a substantial profit after losses earlier in fiscal 2026.
  • Robust cash generation: Operating cash flow of $511.5 million and estimated free cash flow of $459.5 million provide meaningful funding for debt service and dividends.
  • Debt reduction progress: Long-term debt has declined from approximately $7.69 billion at the end of fiscal 2022 to $5.36 billion currently, and Q1 fiscal 2027 financing activity produced a net debt repayment.
  • Working-capital improvement: Inventory declined to $1.05 billion from $1.17 billion a year earlier, while the latest change in operating assets and liabilities contributed $43.7 million of cash.
  • Liquidity is adequate but cash is limited: Current assets of $2.49 billion exceeded current liabilities of $1.29 billion, but cash alone was only $272.3 million.
  • Share count is broadly stable: Basic weighted-average shares increased to 542.5 million from 539.2 million a year earlier, suggesting only modest dilution.
  • Dividend coverage requires monitoring: The $274.7 million common dividend payment exceeded the $202.0 million of net income attributable to common shareholders in Q1 fiscal 2027, although operating cash flow covered the payment.
  • High intangible-asset exposure: Goodwill and intangible assets represented approximately 60% of total assets, increasing the potential impact of future impairment charges if operating conditions weaken.
11/16/26 02:01 PM ETAI Generated. May Contain Errors.

Microchip Technology Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Microchip Technology's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Microchip Technology's net income appears to be on an upward trend, with a most recent value of $230 million in 2026, falling from $323.90 million in 2016. The previous period was -$500 thousand in 2025. See where experts think Microchip Technology is headed by visiting Microchip Technology's forecast page.

Microchip Technology's total operating income in 2026 was $490.10 million, based on the following breakdown:
  • Total Gross Profit: $2.72 billion
  • Total Operating Expenses: $2.23 billion

Over the last 10 years, Microchip Technology's total revenue changed from $2.17 billion in 2016 to $4.71 billion in 2026, a change of 116.9%.

In the past 12 quarters, Microchip Technology's cash and equivalents has ranged from $236.80 million in Q2 2026 to $586 million in Q3 2025, and is currently $457 million as of their latest financial filing in Q2 2027.

Microchip Technology had total debt of $5.50 billion at the end of 2026, a 2.4% decrease from 2025, and a 124.0% increase since 2016.

Over the last 10 years, Microchip Technology's book value per share changed from 10.57 in 2016 to 11.89 in 2026, a change of 12.5%.



Financial statements for NASDAQ:MCHP last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners